Miguel Ángel González-Gay Selected Research

Enzymes

1/2022

WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel Ángel González-Gay Research Topics

Disease

17	Rheumatoid Arthritis 02/2024 - 03/2015
10	Insulin Resistance 02/2024 - 07/2022
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2024 - 01/2018
6	Atherosclerosis 02/2024 - 12/2017
6	Carotid Artery Diseases 02/2024 - 11/2022
6	Systemic Scleroderma (Systemic Sclerosis) 12/2023 - 11/2012
6	Obesity 01/2023 - 07/2016
5	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 05/2020
4	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 05/2020
4	Inflammation (Inflammations) 09/2023 - 01/2022
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 11/2022
3	Axial Spondyloarthritis 01/2023 - 01/2022
3	Aortitis 01/2023 - 05/2014
3	Osteoarthritis 01/2022 - 07/2016
2	Giant Cell Arteritis (Horton Disease) 01/2024 - 01/2023
2	Neoplasms (Cancer) 01/2023 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2022
2	Necrosis 01/2023 - 09/2022
2	Arthritis (Polyarthritis) 01/2022 - 07/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2020
2	Fibrosis (Cirrhosis) 01/2022 - 01/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2017
2	Psoriatic Arthritis 10/2021 - 01/2020
2	Ankylosing Spondylitis 01/2021 - 01/2020
2	Multiple Sclerosis 01/2020 - 01/2018
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 12/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 05/2024
1	digital ulcers 12/2023
1	Calcinosis 12/2023
1	Disease Progression 12/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023
1	Idiopathic Pulmonary Fibrosis 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Arteriosclerosis 01/2023
1	Overweight 01/2023
1	Migraine Disorders (Migraine) 01/2022
1	Gout 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Starvation 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Idiopathic Interstitial Pneumonias 04/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 09/2020

Drug/Important Bio-Agent (IBA)

7	LipidsIBA 02/2024 - 01/2022
4	Biomarkers (Surrogate Marker)IBA 05/2024 - 12/2017
4	tocilizumab (atlizumab)FDA Link 01/2024 - 05/2014
4	CytokinesIBA 12/2023 - 01/2022
4	Interleukin-6 (Interleukin 6)IBA 12/2023 - 05/2014
4	AdipokinesIBA 01/2023 - 07/2016
4	GlucocorticoidsIBA 12/2022 - 01/2022
3	Prednisone (Sone)FDA LinkGeneric 05/2024 - 01/2022
3	Antirheumatic Agents (DMARD)IBA 01/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
2	AntibodiesIBA 05/2024 - 03/2015
2	anti-scl-70 autoantibodiesIBA 12/2023 - 07/2015
2	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 01/2022
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2023 - 01/2022
2	C-PeptideIBA 01/2023 - 07/2022
2	Insulin (Novolin)FDA Link 01/2023 - 07/2022
2	InterleukinsIBA 11/2022 - 01/2020
2	ApolipoproteinsIBA 11/2022 - 07/2020
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 10/2020
2	C-Reactive ProteinIBA 10/2021 - 01/2021
2	Rheumatoid FactorIBA 10/2020 - 01/2020
2	Ligases (Synthetase)IBA 09/2020 - 05/2020
2	Vitamin D FDA LinkGeneric 03/2019 - 11/2012
1	Azathioprine (Imuran)FDA LinkGeneric 05/2024
1	Malondialdehyde (Propanedial)IBA 02/2024
1	Genetic Markers (Genetic Marker)IBA 12/2023
1	LDL CholesterolIBA 10/2023
1	CholesterolIBA 10/2023
1	HDL LipoproteinsIBA 09/2023
1	HDL CholesterolIBA 09/2023
1	Endothelin-1 (Endothelin 1)IBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2023
1	Apolipoprotein C-IIIIBA 01/2023
1	AdiponectinIBA 01/2023
1	LeptinIBA 01/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Interleukin-1 (Interleukin 1)IBA 12/2022
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2022
1	Islet Amyloid PolypeptideIBA 07/2022
1	Everolimus FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	DiureticsIBA 01/2022
1	EnzymesIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Uric Acid (Urate)IBA 01/2022
1	Calcitonin Gene-Related PeptideIBA 01/2022
1	Janus KinasesIBA 10/2021
1	Janus Kinase InhibitorsIBA 10/2021
1	tofacitinibIBA 10/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021
1	Rituximab (Mabthera)FDA Link 09/2020
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 07/2020
1	Antinuclear AntibodiesIBA 05/2020

Therapy/Procedure

9	Therapeutics 01/2023 - 12/2017
2	Biological Therapy 09/2022 - 01/2020
1	Lung Transplantation 05/2020